Management of women who test positive for high-risk types of human papillomavirus: the HART study (Q34282635)

1 August 2017

Management of women who test positive for high-risk types of human papillomavirus: the HART study (English)

1 reference

1 August 2017

C Brooks

11

0 references

Usha Menon

object named as

U Menon

8

0 references

Peter Sasieni

object named as

P Sasieni

17

0 references

author name string

J Cuzick

1

1 reference

1 August 2017

A Szarewski

2

1 reference

1 August 2017

H Cubie

3

1 reference

1 August 2017

G Hulman

4

1 reference

1 August 2017

H Kitchener

5

1 reference

1 August 2017

D Luesley

6

1 reference

1 August 2017

E McGoogan

7

1 reference

1 August 2017

G Terry

9

1 reference

1 August 2017

R Edwards

10

1 reference

1 August 2017

M Desai

12

1 reference

1 August 2017

C Gie

13

1 reference

1 August 2017

L Ho

14

1 reference

1 August 2017

I Jacobs

15

1 reference

1 August 2017

C Pickles

16

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

1 August 2017

6

1 reference

inferred from page(s)

published in

The Lancet

1 reference

1 August 2017

362

1 reference

1 August 2017

9399

1 reference

1 August 2017

1871-1876

1 reference

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914955-0

7 January 2021

Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914955-0

7 January 2021

Human papillomavirus testing in primary cervical screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914955-0

7 January 2021

HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914955-0

7 January 2021

Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914955-0

7 January 2021

HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914955-0

7 January 2021

Screening for cervical intraepithelial neoplasia grade 2/3: validity of cytologic study, cervicography, and human papillomavirus detection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914955-0

7 January 2021

Human papillomavirus DNA testing for cervical cancer screening in low-resource settings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914955-0

7 January 2021

HPV testing in primary screening of older women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914955-0

7 January 2021

Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914955-0

7 January 2021

Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914955-0

7 January 2021

Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914955-0

7 January 2021

Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914955-0

7 January 2021

Could HPV testing become the sole primary cervical screening test?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914955-0

7 January 2021

Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914955-0

7 January 2021

Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914955-0

7 January 2021

Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914955-0

7 January 2021

10.1016/S0140-6736(03)14955-0

Identifiers

DOI

1 reference

1 August 2017

1 reference